FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:1148-1150 October 26, 1995 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

In gastroesophageal reflux disease, a failure of the barrier function between the stomach and the esophagus allows an excessive reflux of gastric or duodenogastric contents. Reflux disease is often chronic and tends to relapse. Although the disease often does not progress, it does in some patients. In up to 20 percent of patients, complications ultimately develop, such as stricture or columnar metaplasia. Relapse often occurs because underlying motor abnormalities are not improved after a course of medical therapy. Current therapy is based on reducing the amount of the refluxed material and its potential to cause injury by suppressing acid secretion . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Bursey, F., Crowley, M., Janes, C., Turner, C. J. (2000). Cost analysis of a provincial drug program to guide the treatment of upper gastrointestinal disorders. CMAJ 162: 817-823 [Abstract] [Full Text]  
• Iannettoni, M. D., Lee, S. S., Bonnell, M. R., Sell, T. L., Whyte, R. I., Orringer, M. B., Beer, D. G. (1996). Detection of Barrett's Adenocarcinoma of the Gastric Cardia With Sucrase Isomaltase and p53. Ann. Thorac. Surg. 62: 1460-1465 [Abstract] [Full Text]